Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Progress in Cardiovascular Diseases|August 22, 2021
The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularizationRam D Bhatt, Peter Libby, Subodh Verma, et al.
Biochimica Et Biophysica Acta|October 31, 2006
Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysisHyesun P McNulty, Jungsoo Byun, Samuel F Lockwood, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 6, 2018
Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statinR Preston Mason, Hazem Dawoud, Robert F Jacob, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 31, 2021
Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailabilitySamuel C R Sherratt, Hazem Dawoud, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|June 25, 2018
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia ManagementOm P Ganda, Deepak L Bhatt, R Preston Mason, et al.
Biochimica Et Biophysica Acta|October 9, 2016
Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranesR Preston Mason, Robert F Jacob, Sandeep Shrivastava, et al.
The Journal of Biological Chemistry|January 9, 2007
Regulation of the gating of BKCa channel by lipid bilayer thicknessChunbo Yuan, Robert J O'Connell, Robert F Jacob, et al.
Journal of the American Heart Association|July 3, 2024
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During InflammationSamuel C R Sherratt, Peter Libby, Hazem Dawoud, et al.
Cardiovascular Research|August 25, 2025
Eicosapentaenoic acid (EPA) limits the more rapid oxidation of lipoprotein(a) [Lp(a)] compared with other ApoB particlesSamuel C R Sherratt, Peter Libby, Richard L Dunbar, et al.
Journal of Cardiovascular Pharmacology|August 31, 2012
Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive ratsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Pageof 10